Skip to content

Cardiac AResT And GENEtic

Etude Multicentrique en Population de la susceptibilité génétique à Faire Une Mort Subite

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00604149
Acronym
CARTAGENE
Enrollment
2332
Registered
2008-01-30
Start date
2008-01-01
Completion date
2014-01-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out-of-hospital Cardiac Arrest

Brief summary

Sudden death is a major problem in industrially developed countries. Despite a decline in ischemic heart disease mortality and the progress has been made in resuscitation, treatment of sudden death victims is frequently unsuccessful. the ideal solution would be to prevent the disease process that causes the initial episode of cardiac arrest. Parental sudden death is an independent risk factor for sudden death. So, detect a gene predisposing to sudden death may help provide better identification of subjects at high risk of cardiac arrest. This research is a genetic study of sudden cardiac death, recruited 2000 subjects in out-of-hospital cardiac arrest.

Interventions

None listed

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* OHCA * Aged from 18 to 75 years

Exclusion criteria

* Pregnant * People not free * Inhospital subjects * Death by other disease * Violent death

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Single Nucleotide Polymorphism (SNP) across the entire genomeDay 1DNA extracted from blood cells

Countries

France

Contacts

PRINCIPAL_INVESTIGATORXavier Jouven, PhD, MD

Institut National de la Santé Et de la Recherche Médicale, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026